Efavirenz, an HIV drug, shows potential for treating chikungunya virus, inhibiting replication and reducing viral load ...

That's why scientists studying AIDS continue to search for weak spots in the virus's infection cycle. HIV inserts its genes into the host cell's nucleus in an unusual way. It doesn't import its ...

Bay Area drug giant Gilead is plotting the trial of a groundbreaking, once-a-year HIV prevention drug lenacapavir.

Discover why starting HIV treatment promptly preserves immune function, prevents transmission, improves quality of life and ...

New research into how a retrovirus is spreading across populations of wild koalas in Queensland, Australia is leading to a ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety ...

The Red Ribbon Club of Salesian College of Higher Education, in collaboration with the National Service Scheme (NSS) and the ...

SOME Nigerians, with a wrong intent to mock, believe that sick people, especially those living with Human Immunodeficiency Virus (HIV) in Africa, particularly Nigeria, are now an “endangered species” ...

Protein crystallization at the SER-CAT beamline at Argonne’s Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.

A group of leading African researchers trying to develop effective vaccines against HIV is trying to figure out how to ...